Schroder Investment Management Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$41.4K 1237
2023
Q4
$41.4K Buy
+10,000
New +$41.4K ﹤0.01% 1175